October 11, 2021 View Now | RDCA-DAP Professional Webinar Series: RDCA-DAP Data Ingestion and Curation Process When: Nov. 10, 2021 | 10 a.m. ET What: In this month’s webinar, describes RDCA-DAP’s data management practices
October 27, 2021 View Now | RDCA-DAP Professional Webinar Series: RDCA-DAP Collaboration with Clinerion for Real World Data Solutions When: Oct. 27, 2021 | 10 a.m. ET What: In this webinar, Clinerion scientists will present an existing rare disease use case
September 29, 2021 Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review C-Path's Huntington's Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based...
September 24, 2021 Critical Path for Parkinson’s Consortium 3DT Initiative: Recommendations for involving people with Parkinson’s in clinical studies using digital health tools Recommendations for involving people with Parkinson’s in clinical studies using digital health tools
November 3, 2021 WEBINAR | Biomarkers of Effect: Safety Biomarkers as Disease Biomarkers When: November 3, 2021 – 10 a.m. US ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webi
C-Path Appoints Tufts’ Jonathan M. Davis as Senior Advisor in Pediatrics TUCSON, Ariz., September 16, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jonathan M. Davis, M.D.,
Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program C-Path, NORD and FDA host annual meeting, demonstration and launch of new rare disease data and analytics platform. TUCSON, Ariz.
September 14, 2021 Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
C-Path and RARE-X Establish New Collaboration for Rare Disease Data Sharing RARE-X and Critical Path Institute align on their mission and commitment for data sharing to improve rare disease research TUCSON,
Breaking Down Data Siloes: New Analytics Platform Sparks Opportunity for Rare Disease Field C-Path, NORD and FDA have spent two years building the platform set to launchSept. 14 at the 2021 RDCA-DAP Workshop. TUCSON, Ariz.